These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4074907)

  • 1. [Combination vindesine, cyclophosphamide, cis-platinum and CCNU in esophageal epidermoid cancer. Preliminary analysis of 64 cases].
    Spielmann M; Kac J; Elias D; Caille P; Le Chevalier T; Rougier P; Zummer K; Lasser P; Rouesse J
    Bull Cancer; 1985; 72(3):220-6. PubMed ID: 4074907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inoperable lung epidermoid cancer non metastasizing. A phase II trial using radiotherapy and combined chemotherapy].
    Le Chevalier T; Arriagada R; Baldeyrou P; Martin M; Ruffié P; Duroux P; Tarayre M; Rouesse J
    Bull Cancer; 1985; 72(1):25-9. PubMed ID: 4039206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Epidermoid cancers of the esophagus: combined chemotherapy, surgery and radiotherapy. Preliminary results in 50 cases].
    Elias D; Lasser P; Kac J; Spielmann M; Eschwege F; Girinsky T; Bertin F; Leclercq B; Nitenberg G; Rougier P
    Bull Cancer; 1988; 75(2):175-81. PubMed ID: 3359061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined chemotherapy (vindesine, lomustine, cisplatin, and cyclophosphamide) and radical radiotherapy in inoperable nonmetastatic squamous cell carcinoma of the lung.
    Le Chevalier T; Arriagada R; Baldeyrou P; Martin M; Duroux P; Jacquotte A; Sancho-Garnier H; Rouesse J
    Cancer Treat Rep; 1985 May; 69(5):469-72. PubMed ID: 4039979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone.
    Ancona E; Ruol A; Santi S; Merigliano S; Sileni VC; Koussis H; Zaninotto G; Bonavina L; Peracchia A
    Cancer; 2001 Jun; 91(11):2165-74. PubMed ID: 11391598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II evaluation of combined cisplatin and vindesine in advanced squamous cell carcinoma of the esophagus: Japanese Esophageal Oncology Group Trial.
    Iizuka T; Kakegawa T; Ida H; Ando N; Watanabe H; Takagi I
    Jpn J Clin Oncol; 1991 Jun; 21(3):176-9. PubMed ID: 1942548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended survival time for esophageal cancer patients treated with aggressive surgery and concurrent chemoradiation.
    Saito T; Shigemitsu Y; Kinoshita T; Shimoda K; Katsuta T; Abe T; Chikuba K; Miyahara M; Kobayashi M
    Int Surg; 1994; 79(2):93-7. PubMed ID: 7928159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin, vindesine, pepleomycin and combined radiation therapy for inoperable esophageal carcinoma.
    Saito T; Kinoshita T; Shigemitsu Y; Shimoda K; Katsuta T; Miyahara M; Kobayashi M; Ashizawa A
    Jpn J Clin Oncol; 1993 Apr; 23(2):123-9. PubMed ID: 7685835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II evaluation of cisplatin, bleomycin, and vindesine in advanced squamous cell carcinoma of the esophagus: a Southeastern Cancer Study Group Trial.
    Dinwoodie WR; Bartolucci AA; Lyman GH; Velez-Garcia E; Martelo OJ; Sarma PR
    Cancer Treat Rep; 1986 Feb; 70(2):267-70. PubMed ID: 2418969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of an exclusive concomitant radio-chemotherapy treatment in non operable esophageal cancer: results of a 10-year experience in Antoine-Lacassagne Center].
    Magné N; François E; Touati L; Marcy PY; Van Houtte P; Lagrange JL
    Bull Cancer; 2005 Feb; 92(2):184-90. PubMed ID: 15749648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase II trial of paclitaxel and cisplatin in patients with locally advanced metastatic esophageal cancer: a preliminary report.
    Kelsen D; Ginsberg R; Bains M; Cooper J; Arquette M; Forastiere AA; Ilson D
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-77-S19-81. PubMed ID: 9427272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisplatin, vindesine, and mitoguazone in the treatment of esophageal cancer.
    Kelsen DP; Fein R; Coonley C; Heelan R; Bains M
    Cancer Treat Rep; 1986 Feb; 70(2):255-9. PubMed ID: 3948190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer.
    Wagenaar HC; Colombo N; Vergote I; Hoctin-Boes G; Zanetta G; Pecorelli S; Lacave AJ; van Hoesel Q; Cervantes A; Bolis G; Namer M; Lhommé C; Guastalla JP; Nooij MA; Poveda A; Scotto di Palumbo V; Vermorken JB
    Gynecol Oncol; 2001 Jun; 81(3):348-54. PubMed ID: 11371121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin, vindesine, and bleomycin (DVB) combination chemotherapy for esophageal carcinoma.
    Kelsen DP; Bains M; Chapman R; Golbey R
    Cancer Treat Rep; 1981; 65(9-10):781-5. PubMed ID: 6168370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paclitaxel in the treatment of patients with upper gastrointestinal carcinomas.
    Ajani JA; Ilson DH; Kelsen DP
    Semin Oncol; 1996 Oct; 23(5 Suppl 12):55-8. PubMed ID: 8941411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effective radiochemotherapy with cisplatin and etoposide for the management of patients with locally inoperable and metastatic esophageal carcinoma.
    Hejna M; Kornek GV; Schratter-Sehn AU; Zach M; Schoder M; Raderer M; Rosen H; Schiessel R; Scheithauer W
    Cancer; 1996 Oct; 78(8):1646-50. PubMed ID: 8859175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Significant role of cisplatin and 5-FU combination chemotherapy for first-line intensive treatment for advanced esophageal cancer].
    Matsui S; Iwazawa T; Yano H; Tono T; Nakano Y; Kanoh T; Kinuta M; Monden T
    Gan To Kagaku Ryoho; 2001 Oct; 28(11):1608-11. PubMed ID: 11707991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Concurrent concentrated radio-chemotherapy of epidermoid cancer of the esophagus. Long-term results of a phase II national multicenter trial in 122 non-operable patients (FFCD 8803)].
    Seitz JF; Milan C; Giovannini M; Dumas F; Cauvin JM; Conroy T; François E; Renard P; Votte-Lambert A; Paillot B; Bedenne L; ;
    Gastroenterol Clin Biol; 2000 Feb; 24(2):201-10. PubMed ID: 12687962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative combined modality therapy with paclitaxel, carboplatin, prolonged infusion 5-fluorouracil, and radiation therapy in localized esophageal cancer: preliminary results of a Minnie Pearl Cancer Research Network phase II trial.
    Meluch AA; Hainsworth JD; Gray JR; Thomas M; Whitworth PL; Davis JL; Greco FA
    Cancer J Sci Am; 1999; 5(2):84-91. PubMed ID: 10198730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of advanced epidermoid carcinoma of the oesophagus with combined 5-fluorouracil, adriamycin and cis-platinum (FAP)].
    Gisselbrecht C; Calvo F; Mignot L; Pujade E; Bouvry M; Danne O; Belpomme D; Morvan F; Marty M
    Nouv Presse Med; 1982 May; 11(24):1859-62. PubMed ID: 6892500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.